Egyptian International Pharmaceutical Investments (CAI:PHAR) Cyclically Adjusted Book per Share: E£26.99 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CAI:PHAR Egyptian International Pharmaceutical Investments CAI:PHAR
70 GF Score
Price E£88.31
GF Value E£59.82
Valuation Significantly Overvalued
! 12 Warning Signs
View Full Analysis

What is Egyptian International Pharmaceutical Investments Cyclically Adjusted Book per Share?

Egyptian International Pharmaceutical Investments CAI:PHAR +2.13% 70 Cyclically Adjusted Book per Share is E£26.99 as of Mar. 2026. GuruFocus rates CAI:PHAR with a GF Score™ of 70/100 and a GF Value™ of E£59.82 (Significantly Overvalued). The stock has 12 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Egyptian International Pharmaceutical Investments's adjusted book value per share for the three months ended in Mar. 2026 was E£33.638. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is E£26.99 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Egyptian International Pharmaceutical Investments's average Cyclically Adjusted Book Growth Rate was 11.00% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 9.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Egyptian International Pharmaceutical Investments was 9.10% per year. The lowest was 9.10% per year. And the median was 9.10% per year.

As of today (2026-07-16), Egyptian International Pharmaceutical Investments's current stock price is E£88.31. Egyptian International Pharmaceutical Investments's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was E£26.99. Egyptian International Pharmaceutical Investments's Cyclically Adjusted PB Ratio of today is 3.27.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Egyptian International Pharmaceutical Investments was 3.40. The lowest was 1.06. And the median was 1.75.


Egyptian International Pharmaceutical Investments  (CAI:PHAR) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Egyptian International Pharmaceutical Investments's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=88.31/26.99
=3.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Egyptian International Pharmaceutical Investments was 3.40. The lowest was 1.06. And the median was 1.75.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Egyptian International Pharmaceutical Investments Cyclically Adjusted Book per Share Related Terms


Egyptian International Pharmaceutical Investments Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Egyptian International Pharmaceutical Investments's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Egyptian International Pharmaceutical Investments Cyclically Adjusted Book per Share Chart

Egyptian International Pharmaceutical Investments Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 18.73 20.87 22.31 24.32

Egyptian International Pharmaceutical Investments Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.32 24.94 25.56 26.15 26.99

CAI:PHAR vs ZTS, UTHR, VTRS: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Egyptian International Pharmaceutical Investments's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Egyptian International Pharmaceutical Investments Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Egyptian International Pharmaceutical Investments's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Egyptian International Pharmaceutical Investments's Cyclically Adjusted PB Ratio falls into.


CAI:PHAR
70GF Score
Egyptian International Pharmaceutical Investments CAI:PHAR
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Egyptian International Pharmaceutical Investments Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Egyptian International Pharmaceutical Investments's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=33.638/330.2130*330.2130
=33.638

Current CPI (Mar. 2026) = 330.2130.

Egyptian International Pharmaceutical Investments Quarterly Data

Book Value per Share CPI Adj_Book
201603 13.779 238.132 19.107
201606 14.598 241.018 20.000
201609 3.577 241.428 4.892
201612 16.512 241.432 22.584
201703 15.175 243.801 20.554
201706 0.000 244.955 0.000
201709 18.643 246.819 24.942
201712 19.569 246.524 26.212
201803 17.121 249.554 22.655
201806 19.106 251.989 25.037
201809 19.326 252.439 25.280
201812 21.539 251.233 28.310
201903 19.369 254.202 25.161
201906 20.764 256.143 26.768
201909 21.723 256.759 27.938
201912 22.879 256.974 29.400
202003 20.135 258.115 25.759
202006 20.647 257.797 26.447
202009 21.254 260.280 26.965
202012 22.419 260.474 28.421
202103 20.995 264.877 26.174
202106 21.711 271.696 26.387
202109 22.394 274.310 26.958
202112 23.040 278.802 27.289
202203 21.717 287.504 24.943
202206 22.283 296.311 24.832
202209 23.375 296.808 26.006
202212 25.124 296.797 27.953
202303 26.308 301.836 28.781
202306 26.755 305.109 28.956
202309 27.415 307.789 29.412
202312 28.620 306.746 30.810
202403 30.045 312.332 31.765
202406 30.876 314.175 32.452
202409 32.213 315.301 33.736
202412 31.285 315.605 32.733
202503 29.410 319.799 30.368
202506 34.826 322.561 35.652
202509 36.751 324.800 37.363
202603 33.638 330.213 33.638

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of E£26.99 mean?
Egyptian International Pharmaceutical Investments (CAI:PHAR) has a Cyclically Adjusted Book per Share of E£26.99 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Egyptian International Pharmaceutical Investments and its competitors.
Is Egyptian International Pharmaceutical Investments' Cyclically Adjusted Book per Share too high?
Egyptian International Pharmaceutical Investments' current Cyclically Adjusted Book per Share is E£26.99. Overall, Egyptian International Pharmaceutical Investments has a GF Score™ of 70/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Egyptian International Pharmaceutical Investments' Cyclically Adjusted Book per Share compare to ZTS and UTHR?
Egyptian International Pharmaceutical Investments' Cyclically Adjusted Book per Share of E£26.99 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Egyptian International Pharmaceutical Investments and its competitors. Egyptian International Pharmaceutical Investments's current Cyclically Adjusted Book per Share is E£26.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Egyptian International Pharmaceutical Investments stock overvalued right now?
Based on GuruFocus' analysis, Egyptian International Pharmaceutical Investments (CAI:PHAR) is currently considered Significantly Overvalued. The stock's GF Value™ is E£59.82, compared to a current price of E£88.31 — trading 47.6% above its estimated fair value. The current Cyclically Adjusted Book per Share is E£26.99. Egyptian International Pharmaceutical Investments' overall GF Score™ is 70/100 with 12 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Egyptian International Pharmaceutical Investments (CAI:PHAR), the current Cyclically Adjusted Book per Share is E£26.99 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Egyptian International Pharmaceutical Investments (CAI:PHAR) Overvalued in 2026?

Based on GuruFocus' analysis, Egyptian International Pharmaceutical Investments stock appears to be overvalued. The current stock price of E£88.31 is trading 47.6% above its estimated GF Value™ of E£59.82. GuruFocus considers Egyptian International Pharmaceutical Investments to be Significantly Overvalued.

Key valuation signals for CAI:PHAR:

  • Cyclically Adjusted Book per Share: E£26.99
  • GF Value™: E£59.82 vs. price of E£88.31 (47.6% above fair value)
  • GF Score™: 70/100 with 12 warning signs

No single metric tells the full story. See the CAI:PHAR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Egyptian International Pharmaceutical Investments Business Description

Address 1st Industrial Zone B1, EIPICO, Tenth of Ramadan City, EGY
Egyptian International Pharmaceutical Investments is an Egypt based company pharmaceutical generic drugs. It holds license agreements with a group of pharmaceutical companies to produce their products locally and replace the imported ones. The company produces dosage forms, Spansule capsules, Antibiotics, Lyophilized Products. It exports its products to African, Asian and East European and Latin American Countries.
70GF Score

Get the complete analysis for CAI:PHAR

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

E£88.31
Price
E£59.82
GF Value